Studies have shown that MSCs can increase the number of FoxP3+ Treg and IFN-γ+ Th1 cells in inguinal lymph nodes in RA mouse models, although they do not affect Th17 cells. This evidence concerns the gene IFNG and rheumatoid arthritis.